Qum Therapeutics

Qum Therapeutics is a biotech startup focused on T-cell engager bispecific antibodies for next-gen immuno-oncology treatments. The name, derived from the Aramaic phrase “Talitha Qum”, means “rise,” while also resonating with the Korean word for “dream” and implying “quiet.” Qum stands for not just healing, but restoring hope—quietly but powerfully.